Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioFCF Payout RatioInventory AverageInvested Capital

Conmed (CNMD) Return on Equity (2016 - 2021)

Historic Return on Equity for Conmed (CNMD) over the last 11 years, with Q3 2021 value amounting to 0.18%.

  • Conmed's Return on Equity fell 5100.0% to 0.18% in Q3 2021 from the same period last year, while for Sep 2021 it was 0.18%, marking a year-over-year decrease of 5100.0%. This contributed to the annual value of 0.05% for FY2025, which is 1000.0% down from last year.
  • Per Conmed's latest filing, its Return on Equity stood at 0.18% for Q3 2021, which was down 5100.0% from 0.37% recorded in Q2 2021.
  • Over the past 5 years, Conmed's Return on Equity peaked at 0.74% during Q1 2020, and registered a low of 0.18% during Q3 2021.
  • Over the past 5 years, Conmed's median Return on Equity value was 0.71% (recorded in 2017), while the average stood at 0.65%.
  • In the last 5 years, Conmed's Return on Equity skyrocketed by 500bps in 2017 and then plummeted by -5100bps in 2021.
  • Over the past 5 years, Conmed's Return on Equity (Quarter) stood at 0.71% in 2017, then increased by 1bps to 0.71% in 2018, then increased by 3bps to 0.74% in 2019, then dropped by -10bps to 0.66% in 2020, then crashed by -73bps to 0.18% in 2021.
  • Its Return on Equity was 0.18% in Q3 2021, compared to 0.37% in Q2 2021 and 0.48% in Q1 2021.